Dillards Reaches New 52-Week High (DDS)

NEW YORK ( TheStreet) -- Dillards (NYSE: DDS) hit a new 52-week high Thursday as it is currently trading at $74, above its previous 52-week high of $72.46 with 485,104 shares traded as of 10:05 a.m. ET. Average volume has been 739,700 shares over the past 30 days.

Dillards has a market cap of $3.11 billion and is part of the services sector and retail industry. Shares are up 56.7% year to date as of the close of trading on Wednesday.

Dillard's, Inc., together with its subsidiaries, operates as fashion apparel, cosmetics, and home furnishing retailer in the United States. The company offers fashion apparel for women, men, and children, as well as accessories and other consumer goods. The company has a P/E ratio of 7.6, above the average retail industry P/E ratio of 7.5 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Dillards as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, notable return on equity, attractive valuation levels and compelling growth in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full Dillards Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus